Tau and Aβ42 in lavage fluid of pneumonia patients are associated with end-organ dysfunction: A prospective

Phoibe Renema1,2,3, Jean-Francois Pittet4, Angela P Brandon4

  • 1Center for Lung Biology, University of South Alabama, Mobile, Alabama, United States of America.

Plos One
|February 23, 2024
PubMed
Abstract

Insights

Bacterial pneumonia and sepsis increase cytotoxic tau and amyloid levels in the lungs, contributing to organ damage in critically ill patients. This study reveals a new mechanism of critical illness injury.

Area of Science:

  • Critical care medicine
  • Neuroscience
  • Pathology

Background:

  • Bacterial pneumonia and sepsis cause organ dysfunction, particularly in vulnerable patients.
  • Pre-clinical studies suggest bacterial infections trigger cytotoxic tau and amyloid release, leading to lung and brain injury.
  • The clinical relevance of these infection-elicited cytotoxins in organ dysfunction remains unclear.

Purpose of the Study:

  • To investigate the presence of cytotoxic tau and amyloids in bronchoalveolar lavage fluid (BALF) of critically ill patients with bacterial pneumonia.
  • To determine if these cytotoxins are associated with end-organ dysfunction in this patient population.

Main Methods:

  • A prospective observational study enrolled mechanically ventilated patients with and without bacterial pneumonia.
  • Levels of tau, amyloid-beta 42 (Aβ42), and BALF cytotoxicity were measured.
  • Cytotoxin concentrations were correlated with clinical data, including measures of end-organ dysfunction.

Main Results:

  • Tau and Aβ42 levels were elevated in patients with culture-positive bacterial pneumonia compared to culture-negative controls.
  • Increased cytotoxins were observed in males and were associated with end-organ dysfunction.
  • Elevated tau and Aβ42 were independent of the specific bacterial organism.

Conclusions:

  • Bacterial infections stimulate the production of cytotoxic tau and Aβ42 within the lungs.
  • These cytotoxins play a role in the development of end-organ dysfunction in critically ill patients.
  • This research highlights an underrecognized pathway contributing to critical illness-related organ injury.